Wang, Yu-Hung http://orcid.org/0000-0003-4483-5627
Lin, Chien-Chin
Gurashi, Kristian
Yao, Chi-Yuan http://orcid.org/0000-0001-5052-9445
Jerez, Andres
Hou, Hsin-An
Chou, Wen-Chien http://orcid.org/0000-0003-2967-698X
Tien, Hwei-Fang http://orcid.org/0000-0002-1384-5593
Batta, Kiran http://orcid.org/0000-0002-3494-0979
Wiseman, Daniel H. http://orcid.org/0000-0003-0715-1402
Funding for this research was provided by:
The Epigenetics of Haematopoiesis Laboratory is funded by grants from The Oglesby Charitable Trust.
Ministry of Health and Welfare (MOHW109-TDU-B-211-134009)
Ministry of Science and Technology, Taiwan (MOST 109-2314-B-002-221, MOST 109-2314-B-002-222, MOST 111-2314-B-002-280)
Article History
Received: 16 April 2024
Revised: 12 June 2024
Accepted: 14 June 2024
First Online: 12 July 2024
Competing interests
: The authors declare no competing interests.
: Use of primary human tissue was in compliance with the ethical and legal framework of the UK’s Human Tissue Act, 2004. Primary samples were from Manchester Cancer Research Centre’s Tissue Biobank instituted with the approval of the South Manchester Research Ethics Committee (18/NW/0092) and licensed by the Human Tissue Authority (license number 30004). Use was authorized following ethical review by the Tissue Biobank’s scientific sub-committee (approval 17_KIBA_01). The NTUH Research Ethics Committee approved the study (#201709072RINC). The study was approved by the institutional review boards of each participating hospital, with informed consent obtained in accordance with the Declaration of Helsinki.